Guengerich FP (xaneiro de 2008). "Cytochrome p450 and chemical toxicology". Chem. Res. Toxicol.21 (1): 70–83. PMID18052394. doi:10.1021/tx700079z.
Danielson PB (decembro de 2002). "The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans". Curr. Drug Metab.3 (6): 561–97. PMID12369887. doi:10.2174/1389200023337054.
Meunier B, de Visser SP, Shaik S (setembro de 2004). "Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes". Chem. Rev.104 (9): 3947–80. PMID15352783. doi:10.1021/cr020443g.
Poulos TL, Finzel BC, Howard AJ (xuño de 1987). "High-resolution crystal structure of cytochrome P450cam". J. Mol. Biol.195 (3): 687–700. PMID3656428. doi:10.1016/0022-2836(87)90190-2.
Sligar SG, Cinti DL, Gibson GG, Schenkman JB (outubro de 1979). "Spin state control of the hepatic cytochrome P450 redox potential". Biochem. Biophys. Res. Commun.90 (3): 925–32. PMID228675. doi:10.1016/0006-291X(79)91916-8.
Chaudhary A, Willett KL (xaneiro de 2006). "Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort". Toxicology217 (2–3): 194–205. PMID16271822. doi:10.1016/j.tox.2005.09.010.
Strandell J, Neil A, Carlin G (febreiro de 2004). "An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies". Phytomedicine11 (2–3): 98–104. PMID15070158. doi:10.1078/0944-7113-00379.
Kroon LA (setembro de 2007). "Drug interactions with smoking". Am J Health Syst Pharm64 (18): 1917–21. PMID17823102. doi:10.2146/ajhp060414.
Rawal S, Kim JE, Coulombe, R Jr (decembro de 2010). "Aflatoxin B1 in poultry: toxicology, metabolism and prevention". Res. Vet. Sci.89 (3): 325–31. PMID20462619. doi:10.1016/j.rvsc.2010.04.011.
Rawal S, Coulombe, RA Jr (agosto de 2011). "Metabolism of aflatoxin B1 in turkey liver microsomes: the relative roles of cytochromes P450 1A5 and 3A37". Toxicol. Appl. Pharmacol.254 (3): 349–54. PMID21616088. doi:10.1016/j.taap.2011.05.010.
McCart C, Ffrench-Constant RH (xuño de 2008). "Dissecting the insecticide-resistance- associated cytochrome P450 gene Cyp6g1". Pest Manag Sci64 (6): 639–45. PMID18338338. doi:10.1002/ps.1567.
Chefson A, Auclair K (2006). "Progress towards the easier use of P450 enzymes". Mol Biosyst.10 (10): 462–9. PMID17216026. doi:10.1039/b607001a.
Chefson A, Zhao J, Auclair K (2006). "Replacement of natural cofactors by selected hydrogen peroxide donors or organic peroxides results in improved activity for CYP3A4 and CYP2D6". Chembiochem6 (6): 916–9. PMID16671126. doi:10.1002/cbic.200600006.
Chefson A, Auclair K. (2007). "CYP3A4 activity in the presence of organic cosolvents, ionic liquids, or water-immiscible organic solvents". Chembiochem10 (10): 1189–97. PMID17526062. doi:10.1002/cbic.200700128.
Guengerich FP (xaneiro de 2008). "Cytochrome p450 and chemical toxicology". Chem. Res. Toxicol.21 (1): 70–83. PMID18052394. doi:10.1021/tx700079z.
Lamb DC, Lei L, Warrilow AG, Lepesheva GI, Mullins JG, Waterman MR, Kelly SL (2009). "The first virally encoded cytochrome P450". Journal of Virology 83 (16): 8266-9. PMID 19515774
Danielson PB (decembro de 2002). "The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans". Curr. Drug Metab.3 (6): 561–97. PMID12369887. doi:10.2174/1389200023337054.
Meunier B, de Visser SP, Shaik S (setembro de 2004). "Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes". Chem. Rev.104 (9): 3947–80. PMID15352783. doi:10.1021/cr020443g.
Poulos TL, Finzel BC, Howard AJ (xuño de 1987). "High-resolution crystal structure of cytochrome P450cam". J. Mol. Biol.195 (3): 687–700. PMID3656428. doi:10.1016/0022-2836(87)90190-2.
Sligar SG, Cinti DL, Gibson GG, Schenkman JB (outubro de 1979). "Spin state control of the hepatic cytochrome P450 redox potential". Biochem. Biophys. Res. Commun.90 (3): 925–32. PMID228675. doi:10.1016/0006-291X(79)91916-8.
Chaudhary A, Willett KL (xaneiro de 2006). "Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort". Toxicology217 (2–3): 194–205. PMID16271822. doi:10.1016/j.tox.2005.09.010.
Strandell J, Neil A, Carlin G (febreiro de 2004). "An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies". Phytomedicine11 (2–3): 98–104. PMID15070158. doi:10.1078/0944-7113-00379.
Kroon LA (setembro de 2007). "Drug interactions with smoking". Am J Health Syst Pharm64 (18): 1917–21. PMID17823102. doi:10.2146/ajhp060414.
Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, Wang ZT, Yang L (2007). "Inhibition of human liver cytochrome P450 by star fruit juice". J Pharm Pharm Sci10 (4): 496–503. PMID18261370.
Rawal S, Kim JE, Coulombe, R Jr (decembro de 2010). "Aflatoxin B1 in poultry: toxicology, metabolism and prevention". Res. Vet. Sci.89 (3): 325–31. PMID20462619. doi:10.1016/j.rvsc.2010.04.011.
Rawal S, Coulombe, RA Jr (agosto de 2011). "Metabolism of aflatoxin B1 in turkey liver microsomes: the relative roles of cytochromes P450 1A5 and 3A37". Toxicol. Appl. Pharmacol.254 (3): 349–54. PMID21616088. doi:10.1016/j.taap.2011.05.010.
McCart C, Ffrench-Constant RH (xuño de 2008). "Dissecting the insecticide-resistance- associated cytochrome P450 gene Cyp6g1". Pest Manag Sci64 (6): 639–45. PMID18338338. doi:10.1002/ps.1567.
Vanden Bossche H, Marichal P, Gorrens J, Coene MC (setembro de 1990). "Biochemical basis for the activity and selectivity of oral antifungal drugs". Br J Clin Pract Suppl71: 41–6. PMID2091733.
Chefson A, Auclair K (2006). "Progress towards the easier use of P450 enzymes". Mol Biosyst.10 (10): 462–9. PMID17216026. doi:10.1039/b607001a.
Chefson A, Zhao J, Auclair K (2006). "Replacement of natural cofactors by selected hydrogen peroxide donors or organic peroxides results in improved activity for CYP3A4 and CYP2D6". Chembiochem6 (6): 916–9. PMID16671126. doi:10.1002/cbic.200600006.
Chefson A, Auclair K. (2007). "CYP3A4 activity in the presence of organic cosolvents, ionic liquids, or water-immiscible organic solvents". Chembiochem10 (10): 1189–97. PMID17526062. doi:10.1002/cbic.200700128.